Literature DB >> 22032249

The role of microglial mtDNA damage in age-dependent prolonged LPS-induced sickness behavior.

Hiroshi Nakanishi1, Yoshinori Hayashi, Zhou Wu.   

Abstract

Microglia are the main cellular source of oxidation products and inflammatory molecules in the brain during aging. The accumulation of mitochondrial DNA (mtDNA) oxidative damage in microglia during aging results in the increased production of reactive oxygen species (ROS). The increased intracellular ROS, in turn, activates a redox-sensitive nuclear factor-κB (NF-κB) to provoke excessive neuroinflammation, resulting in memory deficits and the prolonged behavioral consequence of infection. Besides its role in regulating the gene copy number, mitochondrial transcription factor A (TFAM) is closely associated with the stabilization of mtDNA structures. Lipopolysaccharide (LPS) induces the generation of ROS from the actively respirating mitochondria as well as NADPH oxidase, and leads to the subsequent activation of the NF-κB-dependent inflammatory pathway in aging microglia. The overexpression of human TFAM improves the age-dependent prolonged LPS-induced sickness behaviors by ameliorating the mtDNA damage and reducing the resultant redox-regulated inflammatory responses. Therefore, 'microglia-aging' plays important roles in the age-dependent enhanced behavioral consequences of infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22032249     DOI: 10.1017/S1740925X1100010X

Source DB:  PubMed          Journal:  Neuron Glia Biol        ISSN: 1740-925X


  13 in total

1.  Protective Effect of Semisynthetic and Natural Flavonoid on Aged Rat Microglia-enriched Cultures.

Authors:  Nataša Mrvová; Martin Škandík; Štefan Bezek; Lucia Račková
Journal:  Neurotox Res       Date:  2019-06-22       Impact factor: 3.911

2.  Anthocyanins control neuroinflammation and consequent memory dysfunction in mice exposed to lipopolysaccharide.

Authors:  Fabiano B Carvalho; Jessié M Gutierres; Andressa Bueno; Paula Agostinho; Adriana M Zago; Juliano Vieira; Pâmela Frühauf; José L Cechella; Cristina Wayne Nogueira; Sara M Oliveira; Caroline Rizzi; Roselia M Spanevello; Marta M F Duarte; Thiago Duarte; Odir A Dellagostin; Cinthia M Andrade
Journal:  Mol Neurobiol       Date:  2016-05-11       Impact factor: 5.590

Review 3.  Advanced therapeutic strategies targeting microglia: beyond neuroinflammation.

Authors:  Min-Soo Kwon
Journal:  Arch Pharm Res       Date:  2022-09-27       Impact factor: 6.010

Review 4.  Chronic oxidative damage together with genome repair deficiency in the neurons is a double whammy for neurodegeneration: Is damage response signaling a potential therapeutic target?

Authors:  Haibo Wang; Prakash Dharmalingam; Velmarini Vasquez; Joy Mitra; Istvan Boldogh; K S Rao; Thomas A Kent; Sankar Mitra; Muralidhar L Hegde
Journal:  Mech Ageing Dev       Date:  2016-09-20       Impact factor: 5.432

5.  Physiological function of microglia.

Authors:  Hiroaki Wake; R Douglas Fields
Journal:  Neuron Glia Biol       Date:  2011-02

Review 6.  Evidence of microglial activation in autism and its possible role in brain underconnectivity.

Authors:  Juan I Rodriguez; Janet K Kern
Journal:  Neuron Glia Biol       Date:  2012-07-06

Review 7.  Microglia communication: Parallels between aging and Alzheimer's disease.

Authors:  Joe C Udeochu; Jeremy M Shea; Saul A Villeda
Journal:  Clin Exp Neuroimmunol       Date:  2016-05-03

8.  Microglial aging in the healthy CNS: phenotypes, drivers, and rejuvenation.

Authors:  Wai T Wong
Journal:  Front Cell Neurosci       Date:  2013-03-13       Impact factor: 5.505

Review 9.  Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways.

Authors:  Michael Maes; Michael Berk; Lisa Goehler; Cai Song; George Anderson; Piotr Gałecki; Brian Leonard
Journal:  BMC Med       Date:  2012-06-29       Impact factor: 8.775

10.  Brazilian green propolis suppresses the hypoxia-induced neuroinflammatory responses by inhibiting NF-κB activation in microglia.

Authors:  Zhou Wu; Aiqin Zhu; Fumiko Takayama; Ryo Okada; Yicong Liu; Yuka Harada; Shizheng Wu; Hiroshi Nakanishi
Journal:  Oxid Med Cell Longev       Date:  2013-08-01       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.